Gilla Kaplan, Director at Tyra Biosciences, Inc. (TYRA), sold 134,934 shares at $36.97 ($3.2M) on 2026-03-25, disclosed to the SEC on 2026-03-27.
Open-market sale of $3.2M TYRA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.97 | 14,295 | $528K | 16.6% |
| 2 | $36.97 | 14,295 | $529K | 16.6% |
| 3 | $2.25 | 53,172 | $120K | 3.8% |
| 4 | $37.75 | 53,172 | $2.0M | 63.0% |
| Total | $23.60 avg | 134,934 | $3.2M | 100% |
| Filing → |
| CELG | SELL | 2018-05-21 | $2.2M | — | Filing → |
| CELG | SELL | 2018-02-20 | $3.5M | — | Filing → |
| CELG | SELL | 2017-09-14 | $1.3M | — | Filing → |